Ms. Georgeta Elena Mihailovici, FNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 17220 N Boswell Blvd, Sun City, AZ 85373 Phone: 623-876-9100 Fax: 623-876-9300 |
Jenna Nicole Manning, NP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 10249 W Thunderbird Blvd, Suite 300, Sun City, AZ 85351 Phone: 623-322-5900 |
News Archive
The drug rimonabant was developed as a treatment for obesity and its myriad of serious health consequences. Despite having its desired effects on weight, which it decreased, and on levels of glucose and fats in the blood, rimonabant was never approved for use in the US because of serious neurological side effects including depression and anxiety. Now, a team of researchers, led by George Kunos, at the National Institutes of Health, Bethesda, and Alexandros Makriyannis, at Northeastern University, Boston, have developed a drug that has the same positive effects in mice on levels of glucose and fats in the blood as rimonabant but none of the neurological side effects.
Emerging Healthcare Solutions, Inc. is pleased to announce the execution of an exclusive option agreement with ThromboVision, Inc. ThromboVision, a Houston-based healthcare diagnostics company committed to enabling people to lead longer and healthier lives, has developed and patented T-GuideĀ®, a new cutting-edge diagnostic test to assist medical professionals with the treatment of heart disease.
Teaching young women how to prevent sexually transmitted infections (STIs) increases condom use and might reduce their number of sexual partners, but little research exists on whether educational programs reduce rates of STIs such as human papillomavirus, according to an updated research review from England.
Researchers at Kumamoto University in Japan have discovered that uric acid, an antioxidant, protects against declining lung function from age or lung disease, especially in women.
Adverse drug reactions are a major issue that cause harm, are costly and restrict treatment options for patients and the development of new drugs. A groundbreaking finding by researchers from the La Jolla Institute for Allergy & Immunology could lead to a new way to dramatically improve drug safety by identifying drugs at risk to cause potentially fatal genetic-linked hypersensitivity reactions before their use in man.
› Verified 7 days ago